US Panel Endorses Widespread Use of Pfizer COVID-19 Vaccine

SHARE NOW

A U.S. government advisory panel has endorsed Pfizer’s coronavirus vaccine, in a major step toward an epic vaccination campaign that could finally conquer the outbreak. The Food and Drug Administration is expected to follow the recommendation issued Thursday by its expert advisers. The group concluded that the shot appears safe and effective against the coronavirus in people 16 and older. A final FDA decision is expected within days. Shots would then begin for health care workers and nursing home residents. Widespread access to the general public is not expected until the spring. By LAURAN NEERGAARD and MATTHEW PERRONE Associated Press
WASHINGTON (AP) —

 

Leave a Reply

We encourage open dialogue but if you disagree with someone, please disagree respectfully. Cruelty will not be tolerated. This is a family-friendly group.

Your email address will not be published. Required fields are marked *